Conferences
ASCO GU 2023: Genomic Alterations in Patients with Prostate Cancer with Liver Metastases
February 17, 2023
ASCO GU 2023: Neoadjuvant Nivolumab + Ipilimumab in Cisplatin-Ineligible Patients with Upper Tract Urothelial Cancer
February 17, 2023
ASCO GU 2023: Early Outcomes from Lutetium Lu-177 Vipivotide Tetraxetan Treatment in Patients Selected for Therapy with Piflufolastat F-18 PET Imaging
February 17, 2023
ASCO GU 2023: A Phase II Clinical Study of Intravesical Photo Dynamic Therapy in Patients with BCG-Unresponsive NMIBC (Interim Analysis)
February 17, 2023
ASCO GU 2023: Racial and Geographical Disparities in Pivotal Bladder Cancer Clinical Trials
February 17, 2023
ASCO GU 2023: Oncologic Outcomes in Patients with Residual Invasive Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy
February 17, 2023
ASCO GU 2023: Benefit of Whole-Pelvis Radiation for Patients with Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment-Weighted Analysis
February 17, 2023
ASCO GU 2023: The Impact of Genomic Biomarkers on a Validated Clinical Risk Prediction Model for Upgrading/upstaging Among Men with Low-Risk Prostate Cancer
February 17, 2023
ASCO GU 2023: Phase Ib/II Study of Neoadjuvant Pembrolizumab and Chemotherapy for T2-4aN0M0 Urothelial Cancer (HCRN GU14-188)
February 17, 2023